stella
beta
Coronary Sinus Reducer Implantation in Patients With Ischaemia and Non-obstructed Coronary Arteries and Coronary Microvascular Dysfunction. — Stella
Recruiting
Back to Refractory Angina trials
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(1 site)
United Kingdom
National Heart and Lung Institute (Brompton Campus), Imperial College London, London
View full record on ClinicalTrials.gov